Skip to main content

Table 1 Clinical characteristics of 115 patients with chest pain in relation to the level of hs-cTnT

From: Consequences of high-sensitivity troponin T testing applied in a primary care population with chest pain compared with a commercially available point-of-care troponin T analysis: an observational prospective study

  Chest pain patients n = 115 hs-cTnT-T < 15 ng/L n = 84 hs-cTnT-T ≥ 15 ng/L n = 31 P value
Demographics
 Age, years 65 ± 14 61 ± 13 76 ± 11 <0.001
 Sex, male 66 (57) 41 (49) 25 (81) 0.003
Risk factors
 Current smokers 15 (13) 12 (14) 3 (10) 0.756
 Diabetes 17 (15) 9 (11) 8 (26) 0.072
 Hypertension 42 (37) 25 (30) 17 (55) 0.017
 Hypercholesterolaemia 34 (30) 22 (26) 12 (39) 0.250
Cardiovascular disease
 Angina pectoris 20 (17) 11 (13) 9 (29) 0.056
 Previous AMI 19 (17) 12 (14) 7 (23) 0.395
 Coronary revascularization 14 (12) 10 (12) 4 (13) 1.000
 Stroke 4 (3.5) 3 (3.6) 1 (3.2) 1.000
 Heart failure 11 (10) 4 (4.8) 7 (23) 0.008
 Aortic valve disease 4 (3.5) 1 (1.2) 3 (9.7) 0.059
 Renal failure clinically diagnosed 1 (0.9) 0 (0) 1 (3.2) 0.270
ECG findings
 Atrial fibrillation 12 (10) 3 (3.6) 9 (29) <0.001
Laboratory findings
 POCT-cTnT >30 ng/L 4 0 4 NAa
 eGFR, mL/min 68 ± 16 71 ± 15 59 ± 15 <0.001
 NT-proBNPb 13 (11) 2 (2.4) 11 (37) <0.001
Other
 Potential causes of increased troponin T in the absence of overt ischaemic heart disease, n (%)c 1 (0.9) 1 (1.2) 0 (0) 1.000
  1. Values are presented as mean ± SD or number (%).
  2. aNot applicable.
  3. b>450 ng/L (<50 years), >900 ng/L (50–75 years), and >1,800 ng/L (>75 years).
  4. cHypertrophic cardiomyopathy or amyloidosis